Waivers, AUS are lenders' hedge against any UAD 3.6 crunch
As UAD 3.6’s Nov. 2 mandate shrinks an aging appraiser pool, AnnieMac and Lower lean on AUS waivers and in-house teams to dodge 2022-style fee spikes and turn-time delays.
Similar Posts
BUX Appoints Juha Ristolainen as Chief Technology Officer | LeapRate
European investment platform BUX has named Juha Ristolainen as its new Chief Technology Officer, bringing in a fintech veteran with more than 25 years of software development experience and 15 years in executive leadership roles. Ristolainen joins BUX after co-founding Upvest, where he served as CTO and built the backend investment infrastructure used by several…
TikTok Tested a Dating Feature That Throws Singles Into Live Chats
For a brief moment, we looked for love in a hopeless place: TikTok. TikTok tested a new dating feature over the past week that thrust users into live group chats with other singles. The tool lived in a section of the app called “hangout” that’s tailored toward multi-guest experiences. It invited users who wanted to…
Jonathon Brooks’ North Carolina Home Where He’ll Recover Following Injury
Carolina Panthers running back Jonathon Brooks is facing another lengthy recovery after suffering a core muscle injury—but he’ll have a comfortable place to recuperate in the form of his $539,000 North Carolina home. Brooks, 23, was placed on injured reserve on Sept. 23 after aggravating a groin injury during the Panthers’ 34-3 victory over the…
Verification, AI, Prequal Products; STRATMOR Tech Survey; Government Program News
Verification, AI, Prequal Products; STRATMOR Tech Survey; Government Program News Did you know that 53 percent of statistics are made up on the spot? “Rob, you recently mentioned that 30 percent of repeat buyers paid cash and did not finance their home. Where did that statistic come from?” The most recent Home Buyers…
Prime Medicine Clears FDA Hurdle For Gene-Editing Therapy Targeting Rare Genetic Disease; Stock Up
(RTTNews) – Prime Medicine, Inc. (Nasdaq: PRME) has received U.S. FDA clearance to begin clinical testing of PM647, a gene-editing therapy designed to treat Alpha-1 Antitrypsin Deficiency, marking another regulatory milestone for the company’s liver-focused genetic medicine pipeline. Alpha-1 Antitrypsin Deficiency (AATD) is a rare inherited disorder caused by mutations in the SERPINA1 gene, which…
World Heart Day: How to cover cardiac risks before an emergency strikes | Personal Finance
September 29 is World Heart Day. Cardiac disease is striking a large number of Indians each year. The bill for treating cardiac ailments can run into several lakh. A base health policy, a super top-up, critical illness cover and an emergency corpus can help families manage the financial strain. They should check how each protection…
